TAFI Deficient Plasma – Thrombin Activatible Fibrinolysis Inhibitor Deficient Plasma

Affinity’s TAFI Deficient Plasma – Thrombin Activatible Fibrinolysis Inhibitor Deficient Plasma is manufactured from pooled normal human plasma depleted of TAFI – Thrombin Activatible Fibrinolysis Inhibitor using antibodies directed to TAFI – Thrombin Activatible Fibrinolysis Inhibitor. Only the highest quality citrated plasma is used as starting material. Our Deficient Plasma products are typically buffered with the addition of HEPES to 20mM final concentration.

All TAFI – Thrombin Activatible Fibrinolysis Inhibitor Deficient Plasma from Affinity Biologicals are for Research Use Only and must not be used for diagnostic applications.